Exam 2 - Alpha/Beta Agonists Flashcards
Recall the basic structure of catecholamines, and how substitutions affect degradation.
Catecholamine structure (benzene ring, two hydroxyl groups).
Substitutions affect receptor specificity and COMT/MAO degradation
Describe the MOA of direct and indirect acting catecholamines.
Direct: Bind directly to adrenergic receptors (e.g., epinephrine).
Indirect: Increase NE release or inhibit reuptake (e.g., amphetamines)
List the major types and subtypes of adrenergic receptors, including their downstream signaling.
Alpha Receptors:
α1 (Gq): Activates phospholipase C (PLC), which increases IP3 and DAG, leading to calcium release and smooth muscle contraction.
α2 (Gi): Inhibits adenylyl cyclase, reducing cAMP, which decreases neurotransmitter release and promotes smooth muscle relaxation
Beta: β1 (Gs): Stimulates adenylyl cyclase, increasing cAMP levels, which enhances heart rate and contractility.
β2 (Gs): Increases cAMP via adenylyl cyclase, leading to smooth muscle relaxation (e.g., bronchodilation).
β3 (Gs): Also increases cAMP, primarily involved in lipolysis in adipose tissue
Define a pressor agent.
Increases blood pressure by vasoconstriction or increasing cardiac output (e.g., norepinephrine)
Describe what happens in the cardiovascular system after the administration of an alpha-
agonist, a beta-agonist, or a mixed agonist.
α-agonist: Vasoconstriction, increased BP.
β-agonist: Increased heart rate, bronchodilation.
Mixed: Combination of effects
List tissues that contain significant numbers of β1 or β2 receptors.
β1: Heart, kidney.
β2: Lungs, skeletal muscle vasculature
Name a typical nonselective α agonist, a selective α2 agonist, a nonselective β agonist, a
selective β1 agonist, selective β2 agonists.
Nonselective α: Phentolamine.
Selective α2: Clonidine.
Nonselective β: Isoproterenol.
Selective β1: Dobutamine.
Selective β2: Albuterol
List tissues that contain significant numbers of α1 or α2 receptors.
α1: Vascular smooth muscle, prostate.
α2: Presynaptic nerve terminals
List the major clinical applications of the adrenoceptor agonists.
Epinephrine: Anaphylaxis.
Norepinephrine: Hypotension.
Albuterol: Asthma
Define the triphasic effects of dopamine.
Low dose: Vasodilation (D1).
Moderate dose: Increased heart rate (β1).
High dose: Vasoconstriction (α1)
Delineate the decision in selecting a specific adrenergic agonist
Based on receptor specificity, clinical indication (e.g., albuterol for β2 in asthma)
List the most common toxicities associated with sympathomimetics
Tachycardia, hypertension, arrhythmias, CNS effects (nervousness, insomnia)